Egenesis Stock
eGenesis is a biotechnology company focused on developing human-compatible organs using gene editing and xenotransplantation. It engineers pig organs by removing viral elements and modifying immunological barriers to enable safe transplantation into human patients.
For more Egenesis stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Mike Curtis, Ph.D. President & Chief Executive Officer |
| Jennifer Bergheiser Chief Business Officer |
